Form 4: Director Faith L. Charles Resigns from Conduit Pharmaceuticals Board, Ceases Section 16 Reporting
SEC Form 4
Faith L. Charles resigned from the Board of Directors of Conduit Pharmaceuticals Inc. on April 16, 2025, and will no longer be subject to Section 16 reporting requirements.
Summary
- Faith L. Charles, a director of Conduit Pharmaceuticals Inc., resigned from her position on the Board of Directors effective April 16, 2025.
- As a result of her resignation, Ms. Charles is no longer subject to Section 16 reporting requirements related to transactions in the company's equity securities.
- On April 16, 2025, Ms. Charles acquired 115,194 shares of Common Stock at a price of $0.8681.
- Ms. Charles disposed of 165,238 shares of Common Stock on April 16, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to a director's resignation, so the sentiment is neutral.
Industry Context
Director resignations are a normal part of corporate governance. The impact on the company depends on the director's role and expertise.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Faith L. Charles | 04/16/2025 | Resignation |
Stakeholder Impact
- Shareholders may react to the news of a director's resignation, depending on the director's profile and the circumstances of their departure.
Key Dates
| Date | Description |
|---|---|
| 04/16/2025 | Faith L. Charles resigned from the Board of Directors of Conduit Pharmaceuticals Inc. |
| 04/16/2025 | Faith L. Charles acquired 115,194 shares of Common Stock at $0.8681 per share. |
| 04/16/2025 | Faith L. Charles disposed of 165,238 shares of Common Stock. |
| 04/17/2025 | Date of signature for the Form 4 filing. |
Keywords
resignation, director, Form 4, Conduit Pharmaceuticals, CDT, Section 16, equity securities, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.